Si-Bone (SIBN) Net Income towards Common Stockholders (2017 - 2026)
Si-Bone (SIBN) posted quarterly Net Income towards Common Stockholders of -$18.4 million for Q1 2026, down 180.81% year-over-year from $22.8 million in Q1 2025, and down 6051.51% quarter-over-quarter from -$299000.0 in Q4 2025.
Si-Bone (SIBN) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
Si-Bone's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at -$18.4 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 180.81% year-over-year to -$18.4 million; the TTM figure through Mar 2026 stood at -$5.4 billion (down 19195.16% YoY), while the FY2025 annual figure was -$127.4 million, up 9.39% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$18.4 million, down from -$299000.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$299000.0 in Q4 2025, with the low at -$5.4 billion in Q3 2025.
- The 5-year median for Net Income towards Common Stockholders is -$11.2 million (2023), against an average of -$325.8 million.
- Peak annual rise in Net Income towards Common Stockholders reached 94.92% in 2025, while the deepest fall reached 81390.17% in 2025.
- Si-Bone's Net Income towards Common Stockholders stood at -$12.0 million in 2022, then climbed by 8.32% to -$11.0 million in 2023, then jumped by 46.35% to -$5.9 million in 2024, then soared by 94.92% to -$299000.0 in 2025, then sank by 6051.51% to -$18.4 million in 2026.
- Business Quant data shows SIBN's Net Income towards Common Stockholders at -$18.4 million in Q1 2026, -$299000.0 in Q4 2025, and -$5.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Si-Bone | 868.19 Mn | 722.25 Mn | 44.55 Mn | -4.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.89 Mn |
| Mar 31, 2026 | -18.39 Mn |
| Dec 31, 2025 | -299,000.00 |
| Sep 30, 2025 | -5.36 Bn |
| Jun 30, 2025 | -13.17 Mn |
| Mar 31, 2025 | -6.55 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -6.58 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -10.81 Mn |
| Dec 31, 2023 | -10.97 Mn |
| Sep 30, 2023 | -9.88 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.20 Mn |
| Dec 31, 2022 | -11.97 Mn |
| Sep 30, 2022 | -13.98 Mn |
| Jun 30, 2022 | -18.37 Mn |
| Mar 31, 2022 | -17.36 Mn |
| Dec 31, 2021 | -10.32 Mn |
| Sep 30, 2021 | -15.81 Mn |